¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"phase 1 study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
longitudinal study
ÃßÀû¿¬±¸
molecular genetic study
ºÐÀÚÀ¯ÀüÇа˻ç
neurophysiological study
½Å°æ»ý¸®ÇÐÀû°Ë»ç
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ¿¬±¸
population study
Àα¸Á¶»ç
preclinical study
ÀÓ»óÀü½ÃÇè, ÀüÀӻ󿬱¸
pressure flow study
¾Ð·Â¿ä·ù°Ë»ç
prospective cohort study
ÀüÇâÄÚȣƮ¿¬±¸
prospective study
ÀüÇ⿬±¸, °èȹ¿¬±¸
real time study
½Ç½Ã°£°Ë»ç
retrospective cohort study
ÈÄÇâÄÚȣƮ¿¬±¸
retrospective study
ÈÄÇ⿬±¸
study
1. ¿¬±¸, Á¶»ç 2. °Ë»ç, °Ë»ö
study design
¿¬±¸¼³°è
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
single blinding study
´Ü¼ø¸Í°Ë¹ý
urodynamic study
¿ä¿ªµ¿Çа˻ç
luteal phase endometrial biopsy
Ȳü±âÀڱ󻸷»ý°Ë
phase contrast
À§»ó´ëÁ¶
luteal phase defect
Ȳü±â°á¼Õ
phase difference
À§»óÂ÷
phase-contrast microscope
À§»óÂ÷Çö¹Ì°æ
phase
»ó, ±â, À§»ó
acceleration phase
ÃËÁø±â, °¡¼Ó±â
active phase
Ȱ¼º±â
latent phase
ÀáÀç±â , Àẹ±â
plateau phase
ÆíÆò±â, °íÁ¶±â
relaxation phase
À̿ϱâ, À̿ϻó
resolution phase
ÇØ¼Ò±â
resting phase
È޽ıâ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
feasibility study
°¡´É¼º¿¬±¸
first pass study
ÀÏÂ÷Åë°ú°Ë»ç
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®Á¶»ç
intervening study
°³ÀÔ¿¬±¸
longitudinal study
ÃßÀû¿¬±¸
microbiologic study
¹Ì»ý¹°Çа˻ç
migrant study
ÀÌÁֹבּ¸
mixing study
È¥ÇÕ°Ë»ç
molecular genetic study
ºÐÀÚÀ¯ÀüÇа˻ç
neurophysiological study
½Å°æ»ý¸®ÇÐÀû°Ë»ç
nonconcurrent study
ºñµ¿½ÃÀû¿¬±¸
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ½ÇÇè
population study
Àα¸Á¶»ç
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acceleration phase
ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
acute phase protein
±Þ¼ºº´±â´Ü¹éÁú
acute phase reactant
±Þ¼º±â ÀÛ¿ë¹°Áú
acute phase reaction
±Þ¼º±â¹ÝÀÀ(¡Ñ¢Úãëë)
acute phase reactive protein
±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
acute phase serum
±Þ¼ºº´±âÇ÷û
acute phase substances
±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
advanced sleep phase syndrome
ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
anal-sadistic phase
Ç×¹®-°¡ÇÐ(½Ã)±â
arterial phase
µ¿¸Æ±â
full erection phase
¿ÏÀü¹ß±â±â
g0 phase
Á¤Áö±â G0±â
g1 phase
ÇÕ¼ºÀü±â G1±â
g2 phase
ÇÕ¼ºÈıâ G2±â
gastric phase
À§»ó(êÖßÓ) À§»êºÐºñ(êÖߤÝÂÝô)ÀÇ .
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
molecular genetic study
ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
nested case control study
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
retrospective study
ÈÄÇâÀû¿¬±¸
single blind study
´ÜÀÏ<¼ø>¸Í°Ë¹ý.
time study
½Ã°£¿¬±¸(¡æÚϼ).
tracer study
ÃßÀûÀÚ¿¬±¸(õÚîæíºæÚϼ).
twin study
½Ö»ý¾Æ¿¬±¸(¡æÚϼ).
twin study
½Ö»ý¾Æ¿¬?¡æÚϼ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½